Idexx Laboratories (IDXX) Current Deferred Revenue (2009 - 2026)
Idexx Laboratories (IDXX) posted Current Deferred Revenue of $40.18 million for Q3 2026, up 12.6% from $35.69 million a year earlier and up 10.4% from the prior quarter.
Idexx Laboratories (IDXX) Current Deferred Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Idexx Laboratories' Current Deferred Revenue came in at $35.26 million, up 4.3% from FY2024.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
- In prior years, Idexx Laboratories' Current Deferred Revenue was $33.8 million in FY2024 (-9.1%), $37.2 million in FY2023 (-2.0%), $37.94 million in FY2022 (-5.2%) and $40.03 million in FY2021 (-6.0%).
- The Q3 2026 figure stands as the highest quarterly Current Deferred Revenue since Q3 2022.
- On a year-over-year basis, Current Deferred Revenue has increased in each of the last four quarters, with an average decline of 1.0% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2026, with growth of 12.6%; the weakest was Q4 2024, with a decline of 9.1%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $36.4 million (Q2 2026), $36.33 million (Q1 2026) and $35.26 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - |
| 10 | Idexx Laboratories | 53.34 Bn | 52.56 Bn | 764.30 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 40.18 Mn |
| Jun 30, 2026 | 36.40 Mn |
| Mar 31, 2026 | 36.33 Mn |
| Dec 31, 2025 | 35.26 Mn |
| Sep 30, 2025 | 35.69 Mn |
| Jun 30, 2025 | 36.32 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 33.80 Mn |
| Sep 30, 2024 | 38.43 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Mar 31, 2024 | 38.19 Mn |
| Dec 31, 2023 | 37.20 Mn |
| Sep 30, 2023 | 37.28 Mn |
| Jun 30, 2023 | 37.78 Mn |
| Mar 31, 2023 | 37.84 Mn |
| Dec 31, 2022 | 37.94 Mn |
| Sep 30, 2022 | 40.81 Mn |
| Jun 30, 2022 | 40.78 Mn |
| Mar 31, 2022 | 40.91 Mn |
| Dec 31, 2021 | 40.03 Mn |
Idexx Laboratories Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IDXX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();